DRADTiP: Drug repurposing for aging disease through drug-target interaction prediction.

Saranya Muniyappan, Arockia Xavier Annie Rayan, Geetha Thekkumpurath Varrieth

Computer Science and Engineering, CEG Campus, Anna University, Chennai, Tamil Nadu, India. Electronic address: [email protected] Science and Engineering, CEG Campus, Anna University, Chennai, Tamil Nadu, India. Electronic address: [email protected]. · pubmed

Paper

Abstract

The greatest risk factor for many non-communicable diseases is aging. Studies on model organisms have demonstrated that genetic and chemical perturbation alterations can lengthen longevity and overall health. However, finding longevity-enhancing medications and their related targets is difficult.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper addresses drug repurposing for aging diseases through drug-target interaction prediction, which is relevant to longevity research as it seeks to identify medications that could potentially enhance longevity and healthspan. However, while the approach is solid, it appears to be an incremental advance rather than a groundbreaking discovery, limiting its overall impact in the field.

Author of this paper? Send a correction.